ID

41409

Beschrijving

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02240238

Link

https://clinicaltrials.gov/show/NCT02240238

Trefwoorden

Versies (3)
  1. 19-01-19 19-01-19 -
  2. 28-09-20 28-09-20 -
  3. 01-10-20 01-10-20 -
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

1 oktober 2020

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Solid Tumors, NSCLC, Biliary and Bladder Cancer NCT02240238

Engels

Eligibility Solid Tumors, NSCLC, Biliary and Bladder Cancer NCT02240238

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
(part 1 only) have a histologically or cytologically confirmed diagnosis of advanced solid tumor that has relapsed or is refractory to standard curative or palliative therapy or has a contraindication to standard therapy.
Beschrijving

Histologically or cytologically confirmed advanced solid neoplasms, recurrent, unresponsive to treatment or with contraindication to standard therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0280100
UMLS CUI [1,2]
C0277556
UMLS CUI [2,1]
C0280100
UMLS CUI [2,2]
C0205269
UMLS CUI [3,1]
C0280100
UMLS CUI [3,2]
C1301624
UMLS CUI [3,3]
C1442989
UMLS CUI [3,4]
C0087111
UMLS CUI [4,1]
C0280100
UMLS CUI [4,2]
C1300072
UMLS CUI [5,1]
C0280100
UMLS CUI [5,2]
C0449575
UMLS CUI [6,1]
C0280100
UMLS CUI [6,2]
C1265900
(part 2 only) have histologically or cytologically confirmed diagnosis of stage iiib or iv nsclc and have received 1 or 2 lines of prior chemotherapy or targeted therapy for stage iiib or iv nsclc (second- or third-line).
Beschrijving

Histologically or cytologically confirmed NSCLC stage iiiv or iv after prior chemotherapy or targeted therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0449575
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C1265900
UMLS CUI [3,1]
C0007131
UMLS CUI [3,2]
C1300072
UMLS CUI [4,1]
C0007131
UMLS CUI [4,2]
C1514457
UMLS CUI [5,1]
C0007131
UMLS CUI [5,2]
C1514463
UMLS CUI [5,3]
C2985566
have measurable disease per response evaluation criteria in solid tumors (recist) version 1.1.
Beschrijving

Measurable Disease (recist)

Datatype

boolean

Alias
UMLS CUI [1]
C1709926
UMLS CUI [2]
C1513041
eastern cooperative oncology group (ecog) performance status of 0 to 1
Beschrijving

Ecog performance

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
have adequate bone marrow reserve, liver function, and renal function
Beschrijving

Adequate bone marrow reserve, liver and renal function

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
have received prior platinum therapy in the past 3 months
Beschrijving

Recent platinum therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C3536920
UMLS CUI [1,2]
C0332185
have received prior cisplatin and gemcitabine concomitantly within the last 6 months or are refractory to cisplatin and gemcitabine.
Beschrijving

Recent therapy with or refractory to cisplatin and gemcitabine

Datatype

boolean

Alias
UMLS CUI [1,1]
C0338265
UMLS CUI [1,2]
C0332185
UMLS CUI [2,1]
C0338265
UMLS CUI [2,2]
C0205269
unresolved toxicity from prior radiation, chemotherapy, or other targeted treatment, including investigational treatment
Beschrijving

Unresolved toxicity from radio-, chemo- or other targeted therapy like investigational therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0443342
UMLS CUI [1,3]
C0279134
UMLS CUI [2,1]
C0600688
UMLS CUI [2,2]
C0443342
UMLS CUI [2,3]
C1514457
UMLS CUI [3,1]
C0600688
UMLS CUI [3,2]
C0443342
UMLS CUI [3,3]
C1514463
UMLS CUI [3,4]
C2985566
UMLS CUI [4,1]
C0600688
UMLS CUI [4,2]
C0443342
UMLS CUI [4,3]
C1514463
UMLS CUI [4,4]
C0949266
pregnant or breast feeding
Beschrijving

Pregnant, breast feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Terug naar het begin van de pagina

Similar models

Eligibility Solid Tumors, NSCLC, Biliary and Bladder Cancer NCT02240238

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Histologically or cytologically confirmed advanced solid neoplasms, recurrent, unresponsive to treatment or with contraindication to standard therapy
Item
(part 1 only) have a histologically or cytologically confirmed diagnosis of advanced solid tumor that has relapsed or is refractory to standard curative or palliative therapy or has a contraindication to standard therapy.
boolean
C0280100 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
C0280100 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C0280100 (UMLS CUI [3,1])
C1301624 (UMLS CUI [3,2])
C1442989 (UMLS CUI [3,3])
C0087111 (UMLS CUI [3,4])
C0280100 (UMLS CUI [4,1])
C1300072 (UMLS CUI [4,2])
C0280100 (UMLS CUI [5,1])
C0449575 (UMLS CUI [5,2])
C0280100 (UMLS CUI [6,1])
C1265900 (UMLS CUI [6,2])
Histologically or cytologically confirmed NSCLC stage iiiv or iv after prior chemotherapy or targeted therapy
Item
(part 2 only) have histologically or cytologically confirmed diagnosis of stage iiib or iv nsclc and have received 1 or 2 lines of prior chemotherapy or targeted therapy for stage iiib or iv nsclc (second- or third-line).
boolean
C0007131 (UMLS CUI [1,1])
C0449575 (UMLS CUI [1,2])
C0007131 (UMLS CUI [2,1])
C1265900 (UMLS CUI [2,2])
C0007131 (UMLS CUI [3,1])
C1300072 (UMLS CUI [3,2])
C0007131 (UMLS CUI [4,1])
C1514457 (UMLS CUI [4,2])
C0007131 (UMLS CUI [5,1])
C1514463 (UMLS CUI [5,2])
C2985566 (UMLS CUI [5,3])
Measurable Disease (recist)
Item
have measurable disease per response evaluation criteria in solid tumors (recist) version 1.1.
boolean
C1709926 (UMLS CUI [1])
C1513041 (UMLS CUI [2])
Ecog performance
Item
eastern cooperative oncology group (ecog) performance status of 0 to 1
boolean
C1520224 (UMLS CUI [1])
Adequate bone marrow reserve, liver and renal function
Item
have adequate bone marrow reserve, liver function, and renal function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Recent platinum therapy
Item
have received prior platinum therapy in the past 3 months
boolean
C3536920 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Recent therapy with or refractory to cisplatin and gemcitabine
Item
have received prior cisplatin and gemcitabine concomitantly within the last 6 months or are refractory to cisplatin and gemcitabine.
boolean
C0338265 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0338265 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
Unresolved toxicity from radio-, chemo- or other targeted therapy like investigational therapy
Item
unresolved toxicity from prior radiation, chemotherapy, or other targeted treatment, including investigational treatment
boolean
C0600688 (UMLS CUI [1,1])
C0443342 (UMLS CUI [1,2])
C0279134 (UMLS CUI [1,3])
C0600688 (UMLS CUI [2,1])
C0443342 (UMLS CUI [2,2])
C1514457 (UMLS CUI [2,3])
C0600688 (UMLS CUI [3,1])
C0443342 (UMLS CUI [3,2])
C1514463 (UMLS CUI [3,3])
C2985566 (UMLS CUI [3,4])
C0600688 (UMLS CUI [4,1])
C0443342 (UMLS CUI [4,2])
C1514463 (UMLS CUI [4,3])
C0949266 (UMLS CUI [4,4])
Pregnant, breast feeding
Item
pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial